1. Short title This Act may be cited as the Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act . 2. Opioid use disorder treatment demonstration program Title XVIII of the Social Security Act ( 42 U.S.C. 1395 et seq.) is amended by inserting after section 1866E ( 42 U.S.C. 1395cc–5 ) the following new section: 1866F. Opioid use disorder treatment demonstration program (a) Implementation of 5-Year demonstration program (1) In general Not later than January 1, 2021, the Secretary shall implement a 5-year demonstration program under this title (in this section referred to as the Program ) to increase access of applicable beneficiaries to opioid use disorder treatment services, improve physical and mental health outcomes for such beneficiaries, and to the extent possible, reduce expenditures under this title. Under the Program, the Secretary shall make payments under subsection (f) to participating care teams (as defined in subsection (c)(1)(A)) for providing opioid use disorder treatment services to applicable beneficiaries participating under the Program. (2) Opioid use disorder treatment services For purposes of this section, the term opioid use disorder treatment services — (A) means, with respect to an applicable beneficiary, services that are furnished for the treatment of opioid use disorders in an outpatient setting and— (i) which are supported by the per applicable beneficiary per month care management fee under subsection (f); or (ii) for which payment may otherwise be made under this title; and (B) includes— (i) medication assisted treatment; (ii) treatment planning; (iii) appropriate outpatient psychiatric, psychological, or counseling services (or any combination of such services); (iv) appropriate social support services